PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.264
https://www.valueinhealthjournal.com/article/S1098-3015(18)33564-2/fulltext
Title :
PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33564-2&doi=10.1016/j.jval.2018.09.264
First page :
Section Title :
Open access? :
No
Section Order :
2008